top of page

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Direxion Daily S&P Biotech Bull 3X ETF (NY:LABU)

295.01 +12.84 (+4.55%)

Streaming Delayed Price Updated: 11:13 AM EDT, Jul 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Direxion Daily S&P Biotech Bull 3X ETF

QURE Stock’s Relentless Rally Continues Today — Here's Why HC Wainwright Is Bullish On uniQure ↗

March 10, 2026

H.C. Wainwright stated that the reported departure of a key U.S. Food and Drug Administration official at the end of April bodes well for uniQure.

Via Stocktwits

Topics Initial Public Offering

Why Did QURE Stock Almost Halve Pre-Market Today? ↗

March 02, 2026

uniQure said the FDA does not agree that Phase I/II data are sufficient to serve as primary evidence of effectiveness for a marketing application for its Huntington’s disease gene therapy, AMT-130.

Via Stocktwits

Biotech Bull ETF Surges To 20-Month High: Analysts Say Medicare’s Drug-Pricing Blow Is Softer Than Feared ↗

November 27, 2025

Pricing updates for major therapies from Novo Nordisk, Teva, AbbVie, and others eased sector worries.

Via Stocktwits

Topics ETFs

SNDX Stock Is The Talk Of The Town Today: Here’s Everything To Know About The Latest FDA Approval ↗

October 24, 2025

Via Stocktwits

Sector Rotation ↗

January 08, 2022

In this video, I discuss sector rotation out of technology stocks and into consumer staple, energy, and bank stocks.

Via Talk Markets

Can These 5 Assets Skyrocket Your Portfolio? ↗

September 22, 2024

Are Verizon, Amazon, Cisco, Amgen, and the S&P Biotech Bull 3X Shares ETF poised to make your portfolio skyrocket? In this video, I take a closer look.

Via Talk Markets

Topics ETFs Stocks

EXCLUSIVE: Beyond The Magnificent Seven — Direxion's Egilinsky Reveals Top Sector Picks ↗

August 30, 2024

Direxion's Ed Egilinsky says there are several sectors could be impacted in the current rotation trade environment.

Via Benzinga

Tech Powers S&P 500, Nasdaq, Leveraged ETFs Win ↗

June 06, 2024

Wall Street piled up strong gains in yesterday’s trading session, with the S&P 500 hitting the 25th record high this year and the Nasdaq Composite Index touching another record.

Via Talk Markets

Topics ETFs Stocks

The 3 Best Leveraged ETFs for April 2024 ↗

April 02, 2024

If you want to speculate on baskets of securities, then these best leveraged ETFs for April could be what the doctor ordered.

Via InvestorPlace

Topics ETFs

5 Best-Performing Leveraged ETFs Of February ↗

March 02, 2024

U.S. stocks rallied in February, with the S&P 500 and the Nasdaq Composite Index recording the best month in nearly a decade. Amid this environment, here are some of the best-performing leveraged...

Via Talk Markets

Topics ETFs Stocks

Stocks To Watch This Week - Sunday, Feb. 11 ↗

February 11, 2024

This week, we take a look at small-cap and mid-cap stocks by using ETFs such as MDY and the leveraged ETF TNA. We also like the look of the LABU ETF.

Via Talk Markets

Topics ETFs

The Week Ahead Commentary - Saturday, Feb. 4 ↗

February 05, 2023

Robert Desmond looks at ETF and individual equities for the week just ended and gives his take on trading for the week to come.

Via Talk Markets

J.P.Morgan Healthcare Conference JPM23: Biotech Rally Favors Smaller Caps ↗

January 17, 2023

Large cap biopharmas that outperformed in 2022 were generally weak last week from profit-taking and portfolio rebalancing.

Via Talk Markets

3 Leveraged ETF Stocks to Buy During This Extreme Uncertainty ↗

February 22, 2022

Here are 3 stocks to buy on dips from scary geopolitical risks from Russia. These leveraged ETFs move extremely fast so bring your Dramamine.

Via InvestorPlace

The Dean Martin, “You’re Nobody ‘Till Somebody Loves You” Stock Market (And Sentiment Results)… ↗

February 11, 2022

China Tech (Alibaba) and Biotech have been the two least-loved sectors in recent weeks, but we believe this is changing.

Via Talk Markets

3 Biotech Stocks to Buy That Are Under Severe Pressure ↗

January 13, 2022

The biotech sector is prone to surprise headlines. But these biotech stocks to buy today have had fallen so much that they hit bottom.

Via InvestorPlace

5 Best Leveraged ETFs of Last Week ↗

December 28, 2021

The S&P 500 hit a record close last week, courtesy of a Santa Clause rally. Wall Street was charged-up with the S&P 500 (up 1.22%), the Dow Jones (up 0.15%), the Nasdaq Composite (up 3.12%) and the...

Via Talk Markets

5 Best-Performing Leveraged ETFs of August ↗

September 01, 2021

Here are some best-performing leveraged equity ETFs from different corners of the market that gained in double digits in August.

Via Talk Markets

The Week In Charts: Figure This Out And You’ll Own The World ↗

August 07, 2021

A discussion on trading hot IPOs and some of the issues that have arisen in recent times.

Via Talk Markets

The Week In Charts: Trading Stuff Part 3 - Trading (Or Not Trading!) OGRes, Russian Dolls, ETFs ↗

July 31, 2021

A look at lessons learned from active trading of IPOs, ETFs, Russian Dolls, and a discussion on what might be the secret to trading-which ironically, is the polar opposite to trading.

Via Talk Markets

The Week In Charts: Trading Stuff Part 2-IPOs, ETFs, And, The Secret To Trading ↗

July 23, 2021

A look at lessons learned from active trading including what might be the secret to trading-which ironically is the polar opposite to trading.

Via Talk Markets

These Were The Stocks David Green Discussed On His Show This Morning ↗

July 06, 2021

David Green made money day trading Bridgeline Digital Inc (NASDAQ:

Via Benzinga

The Week In Charts-Volatility: Rabbit Hole Or Holy Grail? ↗

June 11, 2021

A revisit using volatility to let us know when the elusive

Via Talk Markets

A Biotech ETF For Aggressive, Risk-Tolerant Investors ↗

June 08, 2021

The Direxion Daily S&P Biotech Bull 3X Shares ETF (LABU) seeks the daily investment results, before fees and expenses, of 300% of the performance of the S&P Biotechnology Index for a single day.

Via Talk Markets

Topics Stocks

A Biotech ETF For Aggressive, Risk-Tolerant Investors ↗

June 08, 2021

The biotechnology sector has been on fire thanks to news from Biogen Inc. (NASDAQ: BIIB). The FDA approved its controverisal drug that can treat Alzheimer’s Disease. Not...

Via Benzinga

CrowdStrike Stock Earnings Trade ↗

June 06, 2021

In this video, we review the CrowdStrike stock earnings trade. We also review our top five stocks for the new trading week.

Via Talk Markets

This Biotech Stock Could See A Big Move If It Breaks Out Of The Pennant It's Forming ↗

May 05, 2021

Humanigen Inc. (NASDAQ: HGEN) shares made gains Wednesday following the publication of results from a Phase 3 randomized double-blind placebo-controlled study. The...

Via Benzinga

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

220 S. Main St.
Colville, WA 99114

Hours: Mon.-Fri., 8 a.m.-5 p.m.

509-684-4567
editor@statesmanexaminer.com

Site by Amber S. King – Creative Design

Home
About
Contact
Submissions

bottom of page